Saquinavir and ritonavir (DrugBank: Ritonavir, Saquinavir)
2 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
86 | Pulmonary arterial hypertension | 1 |
265 | Lipodystrophy | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02023450 (ClinicalTrials.gov) | December 2013 | 23/12/2013 | Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension | Pulmonary Arterial Hypertension | Drug: saquinavir and ritonavir | The Third Xiangya Hospital of Central South University | Xiangya Hospital of Central South University | Recruiting | 18 Years | 60 Years | Both | 20 | Phase 0 | China |